B A Kamen

6.1k total citations · 1 hit paper
57 papers, 4.7k citations indexed

About

B A Kamen is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Rheumatology. According to data from OpenAlex, B A Kamen has authored 57 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 19 papers in Molecular Biology and 19 papers in Rheumatology. Recurrent topics in B A Kamen's work include Acute Lymphoblastic Leukemia research (20 papers), Folate and B Vitamins Research (19 papers) and Chronic Myeloid Leukemia Treatments (7 papers). B A Kamen is often cited by papers focused on Acute Lymphoblastic Leukemia research (20 papers), Folate and B Vitamins Research (19 papers) and Chronic Myeloid Leukemia Treatments (7 papers). B A Kamen collaborates with scholars based in United States and Canada. B A Kamen's co-authors include Richard G.W. Anderson, Karen G. Rothberg, Y S Ying, Antonieta Capdevila, Daniel W. Fort, Steven Weitman, Verna Frasca, V R Zurawski, Richard H. Lark and Leslie R. Coney and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

B A Kamen

57 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.

1992 889 citations Steven Weitman, Daniel W. Fort et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B A Kamen United States	28	2.1k	1.1k	780	760	660	57	4.7k
Barton A. Kamen United States	31	2.0k 0.9×	962 0.9×	933 1.2×	452 0.6×	1.2k 1.8×	99	5.1k
Manohar Ratnam United States	31	2.8k 1.3×	1.2k 1.1×	292 0.4×	199 0.3×	1.1k 1.7×	103	5.5k
Larry H. Matherly United States	50	4.0k 1.9×	3.0k 2.7×	1.5k 1.9×	145 0.2×	1.2k 1.8×	203	7.5k
Steven Weitman United States	26	1.2k 0.6×	260 0.2×	326 0.4×	101 0.1×	880 1.3×	94	3.1k
Stefano Ferrari Italy	54	4.3k 2.0×	1.2k 1.1×	235 0.3×	702 0.9×	2.9k 4.4×	225	9.5k
Kenneth A. Thomas United States	47	5.7k 2.7×	251 0.2×	131 0.2×	1.1k 1.5×	1.3k 2.0×	92	8.5k
Rongbao Zhao United States	37	1.8k 0.8×	2.8k 2.6×	582 0.7×	82 0.1×	860 1.3×	89	5.0k
Tor Ny Sweden	47	2.1k 1.0×	139 0.1×	791 1.0×	397 0.5×	440 0.7×	140	6.8k
J.B.M. Boezeman Netherlands	31	971 0.5×	195 0.2×	134 0.2×	270 0.4×	456 0.7×	94	3.8k
John Hood United States	30	4.2k 1.9×	503 0.5×	65 0.1×	769 1.0×	1.1k 1.7×	56	7.2k

Countries citing papers authored by B A Kamen

Since Specialization

Citations

This map shows the geographic impact of B A Kamen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B A Kamen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B A Kamen more than expected).

Fields of papers citing papers by B A Kamen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B A Kamen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B A Kamen. The network helps show where B A Kamen may publish in the future.

Co-authorship network of co-authors of B A Kamen

This figure shows the co-authorship network connecting the top 25 collaborators of B A Kamen. A scholar is included among the top collaborators of B A Kamen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B A Kamen. B A Kamen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cole, Peter D., et al.. (2013). γ-Glutamyl hydrolase modulation and folate influence chemosensitivity of cancer cells to 5-fluorouracil and methotrexate. British Journal of Cancer. 109(8). 2175–2188. 18 indexed citations

Kamen, B A, et al.. (2012). Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro. Cancer Chemotherapy and Pharmacology. 70(1). 113–120. 32 indexed citations

Kamen, B A. (2004). A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Advanced Drug Delivery Reviews. 56(8). 1085–1097. 215 indexed citations

Shuster, JJ, FG Behm, Bruce M. Camitta, et al.. (2000). Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies. Leukemia. 14(2). 232–237. 55 indexed citations

Wilson, Jennifer N., Maaike Hum, M Marling-Cason, et al.. (1998). Phase I and pharmacokinetic trial of aminopterin in patients with refractory malignancies.. Journal of Clinical Oncology. 16(4). 1458–1464. 16 indexed citations

Rosenthal, David I., Robert J. Sinard, B A Kamen, et al.. (1997). Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study.. PubMed. 24(6 Suppl 19). S19–71. 6 indexed citations

Goren, Marshall P., James C. Griener, Raymond Quigley, et al.. (1997). Toxicity, pharmacokinetics, and in vitro hemodialysis clearance of ifosfamide and metabolites in an anephric pediatric patient with Wilms' tumor. Cancer Chemotherapy and Pharmacology. 41(2). 140–146. 28 indexed citations

Quinn, Charles T., et al.. (1997). Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer.. Journal of Clinical Oncology. 15(8). 2800–2806. 143 indexed citations

Shuster, Jonathan J., et al.. (1996). Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.. Journal of Clinical Oncology. 14(10). 2803–2811. 38 indexed citations

10.

Bernini, Juan Carlos, et al.. (1995). Aminophylline for methotrexate-induced neurotoxicity. The Lancet. 345(8949). 544–547. 109 indexed citations

11.

Kreisler, Alexandre, et al.. (1995). Similarity of Folate Receptor Expression in UMSCC 38 Cells to Squamous Cell Carcinoma Differentiation Markers. JNCI Journal of the National Cancer Institute. 87(4). 299–303. 16 indexed citations

12.

Winick, Naomi, Robin McKenna, Jonathan J. Shuster, et al.. (1993). Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.. Journal of Clinical Oncology. 11(2). 209–217. 214 indexed citations

13.

Kamen, B A, Angela K. Smith, & R G Anderson. (1991). The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro.. Journal of Clinical Investigation. 87(4). 1442–1449. 111 indexed citations

14.

Lacey, Stephen W., John M. Sanders, Karen G. Rothberg, Richard G.W. Anderson, & B A Kamen. (1989). Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol.. Journal of Clinical Investigation. 84(2). 715–720. 219 indexed citations

15.

Kamen, B A, Chris A. Johnson, Mingyan Wang, & Richard G.W. Anderson. (1989). Regulation of the cytoplasmic accumulation of 5-methyltetrahydrofolate in MA104 cells is independent of folate receptor regulation.. Journal of Clinical Investigation. 84(5). 1379–1386. 49 indexed citations

16.

Whitehead, V. Michael, B A Kamen, & A. D. Beaulieu. (1987). Levels of Dihydrofolate Reductase in Livers of Birds, Animals, Primates, and Man. PubMed. 4(3). 185–189. 15 indexed citations

17.

Kamen, B A, et al.. (1985). Lack of Dihydrofolate Reductase in Human Tumor and Leukemia Cells In Vivo. PubMed. 2(2). 133–138. 30 indexed citations

18.

Nitschke, R, et al.. (1985). Pediatric oncology group phase II trial of amsacrine in children with solid tumors.. PubMed. 35(1). 199–232. 1 indexed citations

19.

Ungerleider, Richard S., C B Pratt, John S. Holcenberg, et al.. (1985). Phase I trial of mitoxantrone in children.. PubMed. 69(4). 403–7. 15 indexed citations

20.

Krakower, Glenn R. & B A Kamen. (1984). The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ.. Journal of Pharmacology and Experimental Therapeutics. 231(1). 43–47. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact